Promising new approach to treating type 2 diabetes

An estimated 462 million people around the world suffer from Type 2 diabetes, a chronic disease in which the body has problems using sugar as a fuel, leading to a buildup of sugar in the blood and chronic health issues.

Kura partners with Kyowa Kirin to advance AML treatment

The partnership involves commercialising and developing the therapy for treating acute myeloid leukaemia and other hematologic malignancies. Credit: Rachaphak/Shutterstock. Kura Oncology has partnered Kyowa Kirin

November 21, 2024

Philogen, Sun Pharma seek EMA approval for melanoma therapy

Intended to be administered intralesionally for four weeks, Nidlegy aims to enhance the immune response against neoplastic lesions. Credit: New Africa / Shutterstock. Philogen and

June 4, 2024

Study discovers a direct connection between the brain and its surrounding environment

In a recent study of the brain’s waste drainage system, researchers from Washington University in St. Louis, collaborating with investigators at the National Institute of

February 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.